Grantham, Mayo, Van Otterloo & Co (GMO)’s Emergent Biosolutions EBS Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-76,500	Closed	-$6.05M	–	779
2020 Q2	$6.05M	Buy	76,500 +36,300	+90%	+$2.71M	0.04%	221
2020 Q1	$2.33M	Buy	+40,200	New	+$2.32M	0.02%	361
2019 Q2	–	Sell	-11,900	Closed	-$601K	–	722
2019 Q1	$601K	Hold	11,900	–	–	﹤0.01%	558
2018 Q4	$705K	Sell	11,900 -3,800	-24%	-$245K	0.01%	390
2018 Q3	$1.03M	Sell	15,700 -22,296	-59%	-$1.3M	0.01%	372
2018 Q2	$1.92M	Buy	37,996 +22,596	+147%	+$1.18M	0.01%	312
2018 Q1	$811K	Hold	15,400	–	–	0.01%	396
2017 Q4	$716K	Buy	+15,400	New	+$648K	﹤0.01%	398

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s EBS Position: Q3 2020 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Emergent Biosolutions (EBS) in Q3 2020, closing a stake of 76,500 shares — an estimated $6.05M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in EBS in Q4 2017 and held it in 8 quarters. The position peaked at $6.05M in Q2 2020. 358 funds tracked by Wall St. Rank hold EBS as of Q3 2020.

Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Emergent Biosolutions position as of Q3 2020 after selling out during the quarter.
Grantham, Mayo, Van Otterloo & Co (GMO) sold 76,500 Emergent Biosolutions shares in Q3 2020, an estimated $6.05M.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Emergent Biosolutions in Q4 2017 and held it in 8 quarters.
Grantham, Mayo, Van Otterloo & Co (GMO)'s Emergent Biosolutions position peaked at $6.05M in Q2 2020.
358 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2020.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2020, filed 13 Nov 2020.